Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,680,923 papers from all fields of science
Search
Sign In
Create Free Account
PD1 Inhibitor
Known as:
Programmed Cell Death Protein 1 Inhibitor
, Protein PD-1 Inhibitor
An agent designed to interfere with the activity of programmed cell death protein 1 (PD1). PD1 inhibitors block T-cell apoptosis and act as non…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Multiple keratin granulomata: A potential histologic clue to cutaneous squamous cell carcinoma responding to programmed cell death protein 1 inhibitor therapy
Benjamin J Kahn
,
D. Parker
,
M. Yushak
,
B. Stoff
,
T. Blalock
Journal of cutaneous pathology
2019
Corpus ID: 73481581
We present histologic features of a locally advanced cutaneous squamous cell carcinoma (cSCC) treated with the programmed cell…
Expand
2019
2019
PD1 inhibitor-induced apoptotic enteropathy in the duodenum.
A. Blesl
,
F. Rainer
,
M. Pollheimer
Gastrointestinal Endoscopy
2019
Corpus ID: 195770907
2019
2019
Abstract A171: A fully human tissue-based ex vivo cell migration analysis model to study T-cell infiltration and distribution in colorectal cancer liver metastases
Anna Berthel
,
M. Suarez-Carmona
,
+10 authors
N. Halama
Regulating T-cells and Their Response to Cancer
2019
Corpus ID: 86386709
T-cell exclusion by tumors is one of the major obstacles for cancer immunotherapies. In colorectal cancer liver metastasis (CRC…
Expand
2018
2018
OCT4&SOX2‐specific cytotoxic T lymphocytes plus programmed cell death protein 1 inhibitor presented with synergistic effect on killing lung cancer stem‐like cells in vitro and treating drug‐resistant…
Xueyan Zhang
,
F. Hu
,
+7 authors
B. Han
Journal of Cellular Physiology
2018
Corpus ID: 53161358
This study aimed to investigate the synergistic effect of octamer‐binding transcription factor 4 and sex determining region Y‐box…
Expand
2018
2018
Activity of single-agent PD-1 inhibitor (PD-1i) therapy in advanced sarcoma: A single-center retrospective analysis.
Dionisia Quiroga
,
D. Liebner
,
+6 authors
G. Tinoco
2018
Corpus ID: 81811057
2018
2018
THU0025 Florid synovitis after pd1 antagonist therapy is characterised by a marked absence of pd1+ infiltrating t cells
W. Murray-Brown
,
T. Wilsdon
,
+4 authors
M. Wechalekar
THURSDAY, 14 JUNE :
2018
Corpus ID: 81250823
Background Although immunological blockade of checkpoint inhibitors (CIs) for cancer therapy is known to be associated with…
Expand
2016
2016
Exploratory responder analyses of greatest depth of response (DepOR) and survival in patients with metastatic non-small cell lung cancer (mNSCLC) treated with a targeted therapy or immunotherapy.
D. Kazandjian
,
G. Blumenthal
,
+6 authors
R. Pazdur
2016
Corpus ID: 79718740
2590Background: RECIST criteria as a binary output may not fully capture the clinical benefit of targeted therapy and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE